CDC Study Finds Invasive Mold Infections Underappreciated
Analysis based on 24 articles · First reported Jul 29, 2026 · Last updated Jul 31, 2026
The study may increase awareness of invasive mold infections, potentially driving demand for antifungal drugs and diagnostic tests. It could also prompt healthcare facilities to invest in mold prevention and infection control measures, affecting healthcare and pharmaceutical sectors.
A first-of-its-kind U.S. study, published by the United States — Centers for Disease Control and Prevention, suggests invasive mold infections are an underappreciated and potentially deadly threat. The research, led by Jeremy Gold, detected about 450 cases in Atlanta-area hospitals over five years (2020-2024), with about a third of patients dying in the hospital. The study found hospitals can expect 3 to 5 cases per year per 100 inpatient beds, with higher rates at larger academic hospitals. Most patients had impaired immune systems or were weakened by COVID-19. The study highlights that mold exposure is a recurring problem after natural disasters influenced by climate change, and the frequency of fungal infections may increase. Jeffrey Jenks of Duke University called the findings valuable but noted the need for similar studies in other regions. The United States does not require doctors to report these illnesses, making this estimate significant.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard